Gene Query: H2AFJ

Dataset Description Geneva Score
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 64.45
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 56.08
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 56.08
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 46.28
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 43.46
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 40.7
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 40.7
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 40.66
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 40.66
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 35.22
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 33.64
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 32.64
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 31.57
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 31.11
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 27.7
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 25.76
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 25.76
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 25.52
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 24.53
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 24.21
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 24.21
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 24.08
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 23.93
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 23.65
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 23.34
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 22.37
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 22.09
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 21.56
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 21.16
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 20.45
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 20.27
RNA-Seq analysis of breast cancer cells after shikonin treatment 19.61
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 19.58
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 19.22
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 19.04
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 19.04
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 18.77
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 18.56
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 18.49
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 18.39
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 18.21
High-Throughput Kinetic Analysis of Fractional Killing 17.97
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 17.83
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 17.83
Differentially expressed genes post knock down of lincDUSP26 17.67
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 17.57
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 17.39
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 17.18
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 17.11
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 16.88
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 16.82
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 16.5
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 16.41
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 16.06
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 16.01
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 15.85
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 15.65
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 15.36
Identification of Nrf2 regulated genes by RNA sequencing 15.25
Nrf2 regulated genes in A549 cells 15.25
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 15.15
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 15.15
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 14.94
Gene expression changes in human melanoma cell lines compared to primary melanocytes 14.38
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.26
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 13.97
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 13.86
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 13.77
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.76
Genome wide expression change in LCC2 and MCF-7 cells 13.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 13.61
ARS2 is a general suppressor of pervasive transcription [RNAseq] 13.58
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 13.35
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 13.24
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 13.22
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 13.22
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 13.15
Transcriptome-wide modulation of splicing by the exon junction complex 13.15
The landscape of alternative splicing in aggressive prostate cancers 13.14
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 13.02
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 12.87
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 12.63
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 12.5
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 12.45
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 12.37
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 12.29
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 12.21
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 11.98
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 11.77
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.75
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 11.49
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 11.42
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.27
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 11.23
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 11.2
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 11.15
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 11.05
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 11.02
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 11.0
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 10.88
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 10.88
Role for citron kinase in prostate cancer growth 10.88
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.75
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 10.71
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 10.71
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 10.63
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 10.62
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 10.56
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 10.47
Universal alternative splicing of noncoding exons 10.46
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 10.33
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 10.33
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.3
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 10.28
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 10.21
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 10.21
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 10.07
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 9.93
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 9.76
RNA sequencing of GlyH-101-treated MCF-7 cell line 9.69
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 9.59
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 9.49
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 9.41
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 9.41
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 9.39
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 9.33
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 9.31
CROP-Seq in Primary Human T Cells 9.26
Epigenomic landscape during organ formation in human early embryos 9.2
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 9.14
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 9.09
hTERT promotes cell adhesion and migration independent of telomerase activity 9.05
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 9.03
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 9.01
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 8.96
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 8.96
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 8.89
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 8.79
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.79
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 8.62
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 8.57
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 8.54
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 8.54
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.52
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 8.43
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 8.43
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 8.42
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 8.4
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 8.35
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 8.35
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 8.29
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 8.24
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 8.23
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 8.21
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 8.21
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 8.14
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 8.07
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 8.05
Total RNA sequencing of WT intestinal orgaonids. 8.04
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.98
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.95
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 7.95
Single-nucleotide-resolution mapping of HBV promoters using CAGE 7.92
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 7.9
Chromatin landscape of human visceral and subcutaneous adipocytes 7.88
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.87
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 7.79
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 7.7
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 7.66
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 7.66
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.66
AUF-1 affected genes in human skin cells 7.65
The comparison of high-throughput single-cell RNA-seq methods 7.65
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 7.61
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.58
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.56
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 7.56
Expression data from miR340 overexpressing human A549 cells 7.52
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 7.46
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 7.42
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 7.3
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 7.3
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.29
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.29
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 7.2
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 7.18
RNAseq analysis of ESRP regulated splicing events in prostate cancer 7.16
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 7.15
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 7.15
Transcriptomic and gene ontology profiling of the human corneal cell types 7.15
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 7.09
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.09
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.09
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.07
p63 controls the enhancer landscape during keratinocyte differentiation 7.04
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 7.02
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 7.01
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 7.01
Characterization of parental and rociletinib-resistant derived H1975 cell lines 6.99
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 6.92
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 6.91
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.9
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 6.87
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 6.85
Genome-wide functional assessment of enhancer activities in the human genome 6.83
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.79
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.78
Energy Metabolism during Anchorage-Independence 6.76
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 6.75
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 6.74
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 6.72
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 6.72
A549 cells and MSR-A549 cells 6.7
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.7
METTL3 promotes translation in human cancer cells 6.65
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.64
RNA-sequencing of formalin fixed human primary melanoma tissue 6.6
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.6
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 6.53
Fusion discovery in breast cancer cell line 6.53
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 6.48
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 6.43
TCF7L1 knockdown in pancreatic cancer 6.43
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 6.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 6.4
The conserved transcriptional landscapes in human spermatogenesis 6.37
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 6.34
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.28
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.28
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 6.28
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 6.27
RNAseq of cell lines with knocked in ESR1 mutations 6.26
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.23
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 6.2
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 6.18
Regulation of highly expressed hCINAP on translatome 6.1
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 6.1
RNA-seq of shEZH2 cells 6.09
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.06
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.05
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.05
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 6.02
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 6.01
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 5.95
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 5.93
RNA-seq analysis of breast cancer 5.92
RNA-seq analysis and shRNA screen of breast cancer 5.92
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 5.87
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 5.86
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 5.85
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 5.85
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 5.85
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 5.81
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 5.8
snRNAs as regulators of alternative splicing 5.77
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.77
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.76
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.76
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 5.75
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 5.73
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 5.65
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 5.63
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  5.63
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 5.62
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 5.62
Macrophage Ad5f35 M2 Challenge 5.57
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 5.53
LIN28A Over-expression RNAseq 5.5
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 5.48
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 5.44
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.39
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 5.38
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.37
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 5.32
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.28
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.27
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 5.25
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 5.22
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.22
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 5.22
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 5.22
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 5.22
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 5.22
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 5.2
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.19
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.18
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 5.09
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 5.09
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.04
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.04
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 5.03
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 5.02
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 4.94
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.93
RNA-seq analysis of differentiating human erythroblasts 4.91
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 4.9
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 4.9
Human Treg IL-12 stimulation 4.84
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.82
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 4.8
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.76
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 4.72
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 4.7
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.69
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.69
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.67
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.67
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.66
The transcriptome effect of overexpressing EZH2 in MCF7 4.61
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 4.57
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 4.55
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.44
PTHrP overexpression in MCF7 cells 4.42
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.39
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.39
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 4.39
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 4.3
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 4.28
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 4.24
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 4.2
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.19
Expression profiles of the four human major ectodermal lineages 4.18
Next generation sequencing of small RNAs isolated from exosomes in human semen 4.14
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 4.0
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 4.0
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.99
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.95
Gene expression profile in breast cancer cell lines using RNA sequencing 3.95
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.92
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.83
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.83
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.81
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 3.75
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 3.75
HNF1A deficiency impairs β-cell fate, granule maturation and function 3.73
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 3.72
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.71
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 3.68
Androgen Receptor-regulated genes in prostate cancer cells 3.64
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 3.64
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 3.63
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 3.54
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 3.45
miRNAs affected by antagomiR-17 treatment 3.44
A549 cell transcriptome responses to infection with H7N9 influenza virus 3.43
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.37
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.37
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 3.26
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 3.25
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.22
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.22
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.2
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 3.19
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 3.19
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 3.17
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 3.1
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.02
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 3.01
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 3.0
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 2.97
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 2.97
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.97
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.96
Expression profiling of MCF-7 cells with treatment of TCDD 2.96
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 2.94
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.89
Proteomics identifies a marker signature of MAPKi resistance in melanoma 2.84
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.71
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.68
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.67
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 2.62
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 2.62
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.62
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.62
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.6
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.6
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.59
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.57
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 2.51
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 2.48
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.46
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.46
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 2.44
DRB/GRO-Seq -/+ UV 2.42
Metabolism as an early predictor of DPSCs aging 2.39
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 2.31
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 2.25
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.21
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.19
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.18
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 2.17
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.17
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 2.16
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.12
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.03
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.98
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.98
Finding missing proteins from epigenetically manipulated human cells 1.97
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 1.96
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.93
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.92
Copper Regulation of HIF-1 Transcription Activity 1.92
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.91
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.9
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 1.86
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 1.86
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.84
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.82
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.81
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 1.76
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.7
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 1.69
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 1.69
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 1.68
A single cell reference map for human blood and tissue T cell activation 1.67
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.64
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.64
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.62
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.55
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.55
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.52
The DNA methylation landscape of human melanoma 1.51
The DNA methylation landscape of human melanoma [RNA-Seq] 1.51
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.5
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 1.5
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 1.48
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 1.46
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 1.46
RNA-seq of cancer cell lines treated with T-025 1.21
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.19
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.17
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 1.17
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.15
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.14
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.14
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.12
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 1.11
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.09
mRNA differential expression analysis in a human ex vivo model of chronic wounds 1.08
Leucegene: AML sequencing (part 6) 1.06
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.02
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 0.99
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.96
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.93
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.92
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.88
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.87
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.84
Molecular analysis of renal cell carcinoma with unclassfied histology 0.8
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.8
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.8
mRNA-sequencing of breast cancer subtypes and normal tissue 0.77
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.74
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.7
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.7
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.65
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.63
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 0.63
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.63
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.62
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.58
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 0.57
Gene expression analysis of human adenomas. 0.57
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.54
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.5
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.5
Gene expression of thyroid cancer cell lines 0.42
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.42
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.38
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.38
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.38
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.36
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.36
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.35
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.33
The circadian transcriptional landscape in primary human mammary epithelial cells 0.33
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.31
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.3
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.29
HNRNPM-regulated splicing dependencies in prostate cancer 0.29
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.29
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.28
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.22
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.14
Impact on erythroid progenitor type on erythroid differntiation 0.13
Preclinical model of obesity and ER-positive breast cancer 0.11
The role of the Calcium-Sensing receptor in colorectal cancer 0.1
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.09
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.09
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.07
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.02
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.01
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.01
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.01
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.01
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.01
CDK4/6 inhibitor resistance in prostate cancer 0.0
RNA-Seq and expression data from human adipose tissue 0.0
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation